Special Issue "Management of Early Stage Cervical Cancer"
Deadline for manuscript submissions: 30 October 2021.
Interests: cervical cancer; minimally invasive surgery; fertility sparing treatments; translational medicine; sentinel lymph node concept; gynecological cancers
Interests: cervical cancer; minimally invasive surgery; translational medicine; sentinel lymph node; gynecological cancers
Cervical carcinoma is a common gynecological malignancy, still representing a challenge for oncologic gynecologists around the world.
A proper and accurate preoperative staging of early-stage disease, obtained through advancements of diagnostic procedures (US, MRI, PET scan), allows personalized treatments. Modulation of surgical radicality, fertility sparing therapies, sentinel node technique, concept of ovarian preservation, introduction of translational medicine, and molecular investigations are the cornerstones of cervical cancer treatment that, in recent years, have become increasingly tailored. In this context, management of cervical cancer requires a multidisciplinary approach involving oncologic gynecologists, medical oncologists, radiologists, radiotherapists, and pathologists. The aim of this Special Issue is to focus on new evidence regarding diagnosis and treatment of early-stage cervical cancer, which could lead to an improvement in clinical practice or could set up new research frontiers in the management of this disease.
Dr. Valerio Gallotta
Dr. Luigi Pedone Anchora
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cervical cancer
- fertility sparing
- sentinel lymph node
- radical surgery
- diagnosis and staging
- prognostic characterization
- personalized treatment
- adjuvant therapy
- molecular investigations
- translational medicine